National Medical Products Administration: 76 innovative medical devices approved for market in 2025, a 17% increase year-on-year

According to reporters from the 2026 National Medical Device Supervision and Administration Work Conference, China’s medical device innovation and upgrading will continue to advance in 2025. Statistics show that in 2025, 76 innovative medical devices were approved for market launch, a year-on-year increase of 17%, with a total of 391 approvals. Priority approval was granted to 25 medical devices, a year-on-year increase of 212.5%, with a total of 171 approvals. It is understood that the National Medical Products Administration (NMPA) in 2025 accelerated the approval of high-end medical devices through policy integration, releasing ten measures to promote the innovative development of high-end medical devices, establishing a “global new” medical device debut mechanism in China, selecting ultra-high dose rate radiotherapy products for pilot projects, and actively cultivating Chinese-made “global new” medical devices. China’s real-world research level for medical devices is among the top in the world. (CCTV News)